Cited by 1,829Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and TreatmentsMenopause: Health Impacts and Treatments

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

Open access

Abstract

BACKGROUND: China has a large population of older people, but has not yet undertaken a comprehensive study on the prevalence, risk factors, and management of both dementia and mild cognitive impairment (MCI). METHODS: For this national cross-sectional study, 46 011 adults aged 60 years or older were recruited between March 10, 2015, and Dec 26, 2018, using a multistage, stratified, cluster-sampling method, which considered geographical region, degree of urbanisation, economic development status, and sex and age distribution. 96 sites were randomly selected in 12 provinces and municipalities representative of all socioeconomic and geographical regions in China. Participants were interviewed to obtain data on sociodemographic characteristics, lifestyle, medical history, current medications, and family history, and then completed a neuropsychological testing battery administered by a psychological evaluator. The prevalence of dementia (Alzheimer's disease, vascular dementia, and other dementias) and MCI were calculated and the risk factors for different groups were examined using multivariable-adjusted analyses. FINDINGS: Overall age-adjusted and sex-adjusted prevalence was estimated to be 6·0% (95% CI 5·8-6·3) for dementia, 3·9% (3·8-4·1) for Alzheimer's disease, 1·6% (1·5-1·7) for vascular dementia, and 0·5% (0·5-0·6) for other dementias. We estimated that 15·07 million (95% CI 14·53-15·62) people aged 60 years or older in China have dementia: 9·83 million (9·39-10·29) with Alzheimer's disease, 3·92 million (3·64-4·22) with vascular dementia, and 1·32 million (1·16-1·50) with other dementias. Overall MCI prevalence was estimated to be 15·5% (15·2-15·9), representing 38·77 million (37·95-39·62) people in China. Dementia and MCI shared similar risk factors including old age (dementia: odds ratios ranging from 2·69 [95% CI 2·43-2·98] to 6·60 [5·24-8·32]; MCI: from 1·89 [1·77-2·00] to 4·70 [3·77-5·87]); female sex (dementia: 1·43 [1·31-1·56]; MCI: 1·51 [1·43-1·59]); parental history of dementia (dementia: 7·20 [5·68-9·12]; MCI: 1·91 [1·48-2·46]); rural residence (dementia: 1·16 [1·06-1·27]; MCI: 1·45 [1·38-1·54]); fewer years of education (dementia: from 1·17 [1·06-1·29] to 1·55 [1·38-1·73]; MCI: from 1·48 [1·39-1·58] to 3·48 [3·25-3·73]); being widowed, divorced, or living alone (dementia: from 2·59 [2·30-2·90] to 2·66 [2·29-3·10]; MCI: from 1·58 [1·44-1·73] to 1·74 [1·56-1·95]); smoking (dementia: 1·85 [1·67-2·04]; MCI: 1·27 [1·19-1·36]), hypertension (dementia: 1·86 [1·70-2·03]; MCI: 1·62 [1·54-1·71] for MCI), hyperlipidaemia (dementia: 1·87 [1·71-2·05]; MCI: 1·29 [1·21-1·37]), diabetes (dementia: 2·14 [1·96-2·34]; MCI: 1·44 [1·35-1·53]), heart disease (dementia: 1·98 [1·73-2·26]; MCI: 1·17 [1·06-1·30]), and cerebrovascular disease (dementia: 5·44 [4·95-5·97]; MCI: 1·49 [1·36-1·62]). Nine of these risk factors are modifiable. INTERPRETATION: Dementia and MCI are highly prevalent in China and share similar risk factors. A prevention strategy should be developed to target the identified risk factors in the MCI population to thwart or slow down disease progression. It is also crucial to optimise the management of dementia and MCI as an important part of China's public health system. FUNDING: Key Project of the National Natural Science Foundation of China, National Key Scientific Instrument and Equipment Development Project, Mission Program of Beijing Municipal Administration of Hospitals, Beijing Scholars Program, Beijing Brain Initiative from Beijing Municipal Science & Technology Commission, Project for Outstanding Doctor with Combined Ability of Western and Chinese Medicine, and Beijing Municipal Commission of Health and Family Planning.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-2667(20)30185-7

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study adjusted for confounders associated with both exposure and outcome, identified based on literature review and clinical knowledge.

    “We adjusted for confounders associated with both the exposure and the outcome, which were identified based on the literature review and clinical knowledge [19–21].”

    From Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study (2023) · cites this paper as [20]

    The statistical analysis passage in our copy (labelled “2019 China statistical yearbook”; page unavailable) lists variables included in logistic regression models, supporting the use of adjusted analyses. It does not say that the variables were selected because they were associated with both exposure and outcome, or that selection was based on a literature review and clinical knowledge. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. Yang, 2016, Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang province, China in 2014, Age Ageing, 45, 708, 10.1093/ageing/afw088 · DOI
  2. Llibre Rodriguez, 2008, Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey, Lancet, 372, 464, 10.1016/S0140-6736(08)61002-8 · DOI
  3. Fei, 2009, Prevalence and distribution of cognitive impairment no dementia (CIND) among the aged population and the analysis of socio-demographic characteristics: the community-based cross-sectional study, Alzheimer Dis Assoc Disord, 23, 130, 10.1097/WAD.0b013e318190a59d · DOI
  4. Zhang, 2014, Prevalence of cognitive impairment no dementia in a rural area of Northern China, Neuroepidemiology, 42, 197, 10.1159/000360138 · DOI
  5. Chan, 2013, Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis, Lancet, 381, 2016, 10.1016/S0140-6736(13)60221-4 · DOI
  6. Song, 2014, Age-related deficit accumulation and the risk of late-life dementia, Alzheimers Res Ther, 6, 54, 10.1186/s13195-014-0054-5 · DOI
  7. Maj, 1993, Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study, Arch Clin Neuropsychol, 8, 123, 10.1093/arclin/8.2.123 · DOI
  8. Hachinski, 2012, Optimizing the Hachinski Ischemic Scale, Arch Neurol, 69, 169, 10.1001/archneurol.2011.1698 · DOI
  9. Hughes, 1982, A new clinical scale for the staging of dementia, Br J Psychiatry, 140, 566, 10.1192/bjp.140.6.566 · DOI · Paper page
  10. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  11. Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250 · DOI · Paper page
  12. Jia, 2020, Dementia in China: epidemiology, clinical management, and research advances, Lancet Neurol, 19, 81, 10.1016/S1474-4422(19)30290-X · DOI · Paper page
  13. Jia, 2014, The prevalence of dementia in urban and rural areas of China, Alzheimers Dement, 10, 1, 10.1016/j.jalz.2013.01.012 · DOI
  14. Ohara, 2017, Trends in dementia prevalence, incidence, and survival rate in a Japanese community, Neurology, 88, 1925, 10.1212/WNL.0000000000003932 · DOI
  15. Kim, 2014, Prevalence and trends of dementia in Korea: a systematic review and meta-analysis, J Korean Med Sci, 29, 903, 10.3346/jkms.2014.29.7.903 · DOI
  16. Kalaria, 2008, Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors, Lancet Neurol, 7, 812, 10.1016/S1474-4422(08)70169-8 · DOI · Paper page
  17. Snyder, 2016, Sex biology contributions to vulnerability to Alzheimer's disease: a think tank convened by the Women's Alzheimer's Research Initiative, Alzheimers Dement, 12, 1186, 10.1016/j.jalz.2016.08.004 · DOI · Paper page
  18. Langa, 2017, A comparison of the prevalence of dementia in the United States in 2000 and 2012, JAMA Intern Med, 177, 51, 10.1001/jamainternmed.2016.6807 · DOI · Paper page
  19. Johnston, 2018, Association between patient cognitive and functional status and Medicare total annual cost of care: implications for value-based payment, JAMA Intern Med, 178, 1489, 10.1001/jamainternmed.2018.4143 · DOI
  20. Penninkilampi, 2018, The association between social engagement, loneliness, and risk of dementia: a systematic review and meta-analysis, J Alzheimers Dis, 66, 1619, 10.3233/JAD-180439 · DOI · Paper page
  21. Liu, 2013, A follow-up study of the incidence and risk factors of dementia in two communities in Beijing, Chin J Psychiatry, 46, 356
  22. Pendlebury, 2019, Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study, Lancet Neurol, 18, 248, 10.1016/S1474-4422(18)30442-3 · DOI
  23. Manly, 2008, Frequency and course of mild cognitive impairment in a multiethnic community, Ann Neurol, 63, 494, 10.1002/ana.21326 · DOI
  24. Zhuo, 2012, A five-year follow-up study of mild congnitive impairment in two urban and rural communities in Beijing, Chin Mental Health J, 26, 754
  25. Frankish, 2017, Prevention and management of dementia: a priority for public health, Lancet, 390, 2614, 10.1016/S0140-6736(17)31756-7 · DOI

Cited by

Sorted by citations

Authors
Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., Li, Y., Li, Y., Zhu, M., Jiao, H., Song, Y., Shi, Y., Zhang, H., Gong, M., Wei, C., Tang, Y., Fang, B., Guo, D., Wang, F., Zhou, A., Chu, C., Zuo, X., Yu, Y., Yuan, Q., Wang, W., Li, F., Shi, S., Yang, H., Zhou, C., Liao, Z., Lv, Y., Li, Y., Kan, M., Zhao, H., Wang, S., Yang, S., Li, H., Liu, Z., Wang, Q., Qin, W., Jia, J., Quan, M., Wang, Y., Li, W., Cao, S., Xu, L., Han, Y., Liang, J., Qiao, Y., Qin, Q., & Qiu, Q.
Affiliations
  • Capital Medical University (CN)
  • Shandong University (CN)
  • Guiyang Medical University (CN)
  • Beijing Normal University (CN)
  • Guangxi Medical University (CN)
  • The First Hospital of Kunming (CN)
  • First Hospital of Jilin University (CN)
  • Zhejiang Provincial People's Hospital (CN)
  • Hainan General Hospital (CN)
  • Second Hospital of Hebei Medical University (CN)
  • Daqing Oilfield General Hospital (CN)
  • Gansu University of Traditional Chinese Medicine (CN)
Corresponding author
Jia, Jianping
Venue
The Lancet Public Health
Publisher
Elsevier BV
Published
2020-12
Volume
5
Issue
12
Pages
e661-e671
ISSN
2468-2667 (ISSN-L)
OpenAlex
W3106725626
Cited by
1,829
References
10
Citations by year
2026: 378 · 2025: 466 · 2024: 431 · 2023: 275 · 2022: 209 · 2021: 70
FWCI
92.29
Type
journal article
Language
en
Open access
Locations
  • The Lancet Public Health (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Key Scientific Instrument and Equipment Development Projects of China (31627803)
  • National Natural Science Foundation of China (81530036)
  • Beijing Municipal Administration of Hospitals (SML20150801)
  • Beijing Municipal Science and Technology Commission (Z161100000216137, Z201100005520017, Z201100005520016)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
dementia, mild cognitive impairment, Alzheimer's disease, vascular dementia, dementia prevalence, dementia risk factors, dementia management, older adults, China, neuropsychological assessment, dementia services
MeSH terms
Aged, Aged, 80 and over, China, Cross-Sectional Studies, Dementia, Female, Health Status, Humans, Life Style, Male, Medical History Taking, Middle Aged, Neuropsychological Tests, Residence Characteristics, Risk Factors, Socioeconomic Factors, Prevalence, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review